Abiomed Confident About Five Year Strategy and Pipeline
Abiomed (NSDQ:ABMD) yesterday released 5-year financial growth plans as well as preliminary information on new pipeline products. The full presentation of the company’s long-term growth strategy and vision was presented to investors yesterday in Abiomed’s annual investor conference in Boston.
The company’s plans call for $1.2-$1.8 billion in sales, significantly higher than analyst estimates, according to Morgan Stanley note to investors.
Help employers find you! Check out all the jobs and post your resume
The company’s plans call for $1.2-$1.8 billion in sales, significantly higher than analyst estimates, according to Morgan Stanley note to investors.
Help employers find you! Check out all the jobs and post your resume